121 related articles for article (PubMed ID: 12169178)
1. Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity.
Frezzolini A; Paradisi M; Zaffiro A; Provini A; Cadoni S; Ruffelli M; De Pità O
Allergy; 2002 Sep; 57(9):815-20. PubMed ID: 12169178
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype.
Leonardi S; Cuppari C; Manti S; Filippelli M; Parisi GF; Borgia F; Briuglia S; Cannavò P; Salpietro A; Arrigo T; Salpietro C
Allergy Asthma Proc; 2015; 36(1):74-81. PubMed ID: 25562560
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of NO products, IL-8, RANTES and eotaxin in infantile patients with atopic dermatitis].
Kurita F
Arerugi; 2000 Jul; 49(7):577-84. PubMed ID: 10944824
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD30 in pediatric patients with atopic dermatitis.
Frezzolini A; Paradisi M; Ruffelli M; Cadoni S; De Pità O
Allergy; 1997 Jan; 52(1):106-9. PubMed ID: 9062638
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children.
Hossny E; Aboul-Magd M; Bakr S
Allergy; 2001 Oct; 56(10):996-1002. PubMed ID: 11576081
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
Heshmat NM; El-Hadidi ES
Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
8. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children.
Leung TF; Ma KC; Hon KL; Lam CW; Wan H; Li CY; Chan IH
Pediatr Allergy Immunol; 2003 Aug; 14(4):296-301. PubMed ID: 12911508
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble CD30 in patients with atopic dermatitis: correlations with age, disease duration and severity.
El Mongy S; Metwaly SS; Arafat MS; Hady HA
Egypt J Immunol; 2008; 15(1):123-9. PubMed ID: 20306677
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis.
Dummer W; Bröcker EB; Bastian BC
Br J Dermatol; 1997 Aug; 137(2):185-7. PubMed ID: 9292064
[TBL] [Abstract][Full Text] [Related]
11. Correlations of serum Interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis.
Wu KG; Li TH; Chen CJ; Cheng HI; Wang TY
Int J Immunopathol Pharmacol; 2011; 24(1):15-23. PubMed ID: 21496383
[TBL] [Abstract][Full Text] [Related]
12. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis.
Fujisawa T; Fujisawa R; Kato Y; Nakayama T; Morita A; Katsumata H; Nishimori H; Iguchi K; Kamiya H; Gray PW; Chantry D; Suzuki R; Yoshie O
J Allergy Clin Immunol; 2002 Jul; 110(1):139-46. PubMed ID: 12110833
[TBL] [Abstract][Full Text] [Related]
13. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores.
Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P
Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous CD30+ cells in children with atopic dermatitis.
Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R
Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1.
Kozma GT; Falus A; Bojszkó A; Krikovszky D; Szabó T; Nagy A; Szalai C
Allergy; 2002 Feb; 57(2):160-3. PubMed ID: 11929421
[TBL] [Abstract][Full Text] [Related]
16. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Ezzat MH; Sallam MA; Shaheen KY
Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
[TBL] [Abstract][Full Text] [Related]
17. Soluble immune receptor serum levels are associated with age, but not with clinical phenotype or disease severity in childhood atopic dermatitis.
Ott H; Wilke J; Baron JM; Höger PH; Fölster-Holst R
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):395-402. PubMed ID: 19744181
[TBL] [Abstract][Full Text] [Related]
18. Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers.
Hon KL; Tsang KY; Kung JS; Leung TF; Lam CW; Wong CK
Molecules; 2017 Feb; 22(2):. PubMed ID: 28216598
[TBL] [Abstract][Full Text] [Related]
19. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
[TBL] [Abstract][Full Text] [Related]
20. Levels of soluble CD30 in cord blood and peripheral blood during childhood are not correlated with the development of atopic disease or a family history of atopy.
Holmlund U; Bengtsson A; Nilsson C; Kusoffsky E; Lilja G; Scheynius A; Sverremark-Ekström E
Clin Exp Allergy; 2003 Nov; 33(11):1531-6. PubMed ID: 14616865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
